Anaconda Biomed Names Richard Ferrari Board Chair and Hendrik Lambert CMO

April 20, 2023—Anaconda Biomed, a Spain-based medical device company developing next-generation thrombectomy systems to treat ischemic stroke, announced the appointment of Richard Ferrari as board Chair, and named Hendrik Lambert, PhD, as Chief Medical Officer.

According to the company, Ferrari is Cofounder of De Novo Ventures and has cofounded, led, and advised scores of medical device and biotechnology companies for more than 2 decades, raising approximately $1 billion in financing and participating in approximately $1.8 billion worth of acquisition events for emerging medical technology firms.

Most recently, Ferrari was Chairman and CEO of PQ Bypass, Inc., which was acquired by Endologix LLC for $350 million in 2021. He also led two publicly traded medical device firms, Cardiovascular Imaging Systems and CardioThoracic Systems, to nine-figure acquisitions as CEO. In addition to Anaconda Biomed, he serves as Chairman and board member of multiple medical device and biotech companies.

“Anaconda’s novel and elegant solution to treating neurovascular clots made it easy to accept the role of Chairperson,” stated Ferrari in the company’s press release. “The ability to quickly navigate challenging vessel anatomy, engulf the entire clot, and rapidly restore blood flow is associated with less damage to the brain and better outcomes.”

Dr. Lambert has > 25 years of experience in the development of medical device technologies, ranging from early stage startups to large multinational corporations in the cardiac, vascular, and neurological therapy spaces.

Most recently, Lambert was Cofounder and Vice President of Clinical and Regulatory Affairs at Switzerland-based Onward Medical and helped develop the company’s treatment for patients with spinal cord injuries. He was also Vice President of Clinical and Regulatory Affairs at Endosense, which was acquired by St. Jude Medical (now Abbott), where he developed and executed the global clinical-regulatory strategy. Lambert is also Associate Teaching Professor at the University of Ghent, Belgium.

Anaconda Biomed’s Ana catheter system is an investigational device and is not available for sale in the United States or the European Union.